Long-term outcomes after AKI-a major unmet clinical need.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
01 2019
Historique:
received: 11 09 2018
accepted: 13 09 2018
entrez: 5 1 2019
pubmed: 5 1 2019
medline: 2 4 2019
Statut: ppublish

Résumé

In this issue of Kidney International, a comprehensive systematic review and meta-analysis provides an up-to-date picture of the long-term risks of death, chronic kidney disease (CKD), and end-stage kidney disease (ESKD) that follow an episode of acute kidney injury (AKI). Results confirm the significant event rate of these adverse outcomes following AKI and demonstrate that AKI severity and the clinical setting in which AKI occurs are important determinants of risk. In this commentary we discuss the implications of this study and how the results signal some key priorities for future research in an area of substantial clinical need.

Identifiants

pubmed: 30606416
pii: S0085-2538(18)30674-4
doi: 10.1016/j.kint.2018.09.005
pii:
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-23

Commentaires et corrections

Type : CommentOn

Informations de copyright

Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Nicholas M Selby (NM)

Centre for Kidney Research and Innovation, School of Medicine, University of Nottingham, Derby, UK; Department of Renal Medicine, Derby Teaching Hospitals NHS Foundation Trust, Derby, UK. Electronic address: nicholas.selby@nottingham.ac.uk.

Maarten W Taal (MW)

Centre for Kidney Research and Innovation, School of Medicine, University of Nottingham, Derby, UK; Department of Renal Medicine, Derby Teaching Hospitals NHS Foundation Trust, Derby, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH